Naprosyn
- Product NDC
- 71511-701
- 11-digit product format
- 715110701
- Labeler code
- 71511
- Product ID
- 71511-701_8ae1c41c-a532-4878-bc44-814b2061fdd3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naproxen
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Athena Bioscience, LLC
- Application
- NDA018965
- Marketing category
- NDA
- Marketing start
- 2018-01-01
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 125 mg/5mL
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71511-701-16 | 71511070116 | 473 mL in 1 BOTTLE, PLASTIC (71511-701-16) | 473 ml | 2018-01-01 | 0000-00-00 | No | No | Current |